Successful Osimertinib Rechallenge with Steroid Therapy after Osimertinib-induced Interstitial Lung Disease

Kiriu, T; Tamura, D; Tachihara, M; Sekiya, R; Hazama, D; Katsurada, M; Nakata, K; Nagano, T; Yamamoto, M; Kamiryo, H; Kobayashi, K; Nishimura, Y

Tamura, D (reprint author), Kobe Univ, Grad Sch Med, Dept Internal Med, Div Resp Med, Kobe, Hyogo, Japan.

INTERNAL MEDICINE, 2018; 57 (1): 91

Abstract

A 62-year-old male with lung adenocarcinoma harboring an exon 19 deletion in the Epidermal growth factor receptor (EGFR) was treated with EGFR-tyrosin......

Full Text Link